Andrew J. Murphy
Equibles does not estimate personal net worth.
Get an email with a short summary when Regeneron Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get REGN alertsAbout Andrew J. Murphy
The proxy statement of Regeneron Pharmaceuticals, Inc. reports total compensation of $8,477,119 for Andrew J. Murphy in fiscal 2025, including a base salary of $819,672. Disclosed compensation is on record for 7 fiscal years. Regeneron Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Regeneron Pharmaceuticals, Inc. includes George D. Yancopoulos, M.D., Ph.D. (Chairman), Leonard S. Schleifer, M.D., Ph.D. (Chairman), Joseph J. LaRosa (General Counsel) and 7 others.
Affiliation history
-
Regeneron Pharmaceuticals, Inc. (REGN)
Proxy statement
Current
Company network
Leadership on record at Regeneron Pharmaceuticals, Inc.
- George D. Yancopoulos, M.D., Ph.D. Chairman
- Leonard S. Schleifer, M.D., Ph.D. Chairman
- Joseph J. LaRosa General Counsel
- Christine A. Poon Board Member
- Craig B. Thompson, M.D. Board Member
- David P. Schenkein Board Member
- David P. Schenkein, M.D. Board Member
- Huda Y. Zoghbi, M.D. Board Member
- Joseph L. Goldstein, M.D. Board Member
- Kathryn Guarini Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Co-Chief Scientific Officer | $819,672 | $8,477,119 |
| 2024 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $803,600 | $8,363,257 |
| 2023 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $776,250 | $8,429,311 |
| 2022 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $750,000 | $9,122,529 |
| 2021 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $724,500 | $7,146,830 |
| 2020 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $726,923 | $10,998,914 |
| 2019 | Regeneron Pharmaceuticals, Inc. (REGN) | Executive Vice President, Research | $600,000 | $9,519,347 |
Recent activity
No call appearances or filed executive changes recorded yet.